CRDOF(CRDOF)
CRDOF
No analyst ratings available
No analyst price targets available for CRDOF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $235M | $245M | $260M | $331M | $333M |
| Low | $214M | $204M | $227M | $289M | $291M |
| High | $256M | $267M | $283M | $361M | $364M |
| EBITDA Avg | $96M | $142M | $132M | $145M | $109M |
| Low | $87M | $126M | $119M | $131M | $102M |
| High | $103M | $153M | $141M | $155M | $114M |
| EBIT Avg | $63M | $102M | $86M | $90M | $47M |
| Low | $54M | $86M | $72M | $76M | $40M |
| High | $70M | $113M | $95M | $100M | $51M |
| Net Income Avg | $34M | $58M | $48M | $50M | $25M |
| Low | $29M | $48M | $40M | $42M | $21M |
| High | $38M | $65M | $54M | $56M | $27M |
| EPS Avg | $0.28 | $0.47 | $0.39 | $0.41 | $0.20 |
| Low | $0.23 | $0.39 | $0.33 | $0.34 | $0.17 |
| High | $0.31 | $0.53 | $0.44 | $0.46 | $0.22 |
| Analysts (Rev / EPS) | 3 / 1 | 3 / 1 | 1 / 1 | 1 / 1 | 2 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $64M | $68M | $62M | $62M | $62M | $62M |
| Low | $64M | $68M | $62M | $62M | $62M | $62M |
| High | $64M | $68M | $62M | $62M | $62M | $62M |
| EBITDA Avg | $25M | $32M | $39M | $40M | $40M | $38M |
| Low | $25M | $32M | $39M | $40M | $40M | $38M |
| High | $25M | $32M | $39M | $40M | $40M | $38M |
| EBIT Avg | $15M | $22M | $28M | $28M | $28M | $26M |
| Low | $15M | $22M | $28M | $28M | $28M | $26M |
| High | $15M | $22M | $28M | $28M | $28M | $26M |
| Net Income Avg | $8M | $13M | $17M | $17M | $17M | $15M |
| Low | $8M | $13M | $17M | $17M | $17M | $15M |
| High | $8M | $13M | $17M | $17M | $17M | $15M |
| EPS Avg | $0.06 | $0.09 | $0.12 | $0.12 | $0.12 | $0.11 |
| Low | $0.06 | $0.09 | $0.12 | $0.12 | $0.12 | $0.11 |
| High | $0.06 | $0.09 | $0.12 | $0.12 | $0.12 | $0.11 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |